Brief: Fresenius Medical Care's Third-Party Clinical Research Organization Frenova Announces Strategic Collaboration Advancing Genomics-Driven, Precision Kidney Disease Care
July 31 (Reuters) - FRESENIUS MEDICAL CARE AG FMEG.DE: FRESENIUS MEDICAL CARE'S THIRD-PARTY CLINICAL RESEARCH ORGANIZATION FRENOVA ANNOUNCES STRATEGIC COLLABORATION ADVANCING GENOMICS-DRIVEN, PRECISION KIDNEY DISEASE CARE Source text: ID:nPnRntzka Further company coverage: AZTA.O (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Azenta
See all newsUS RESEARCH ROUNDUP-Adobe, Domino's Pizza, Goldman Sachs
Brief: Azenta - Approves Restructuring Plan Within Multiomics Segment On October 5, 2026
Brooks Automation confidentially files for US IPO (updated)
U.S. STOCKS ON THE MOVE-Azenta, Qiagen NV, Capricor Therapeutics
Azenta names interim CEO after Marotta resigns; shares fall